FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma's generic inhalation powder combination of fluticasone propionate and salmeterol. It is indicated for the treatment of asthma and chronic obs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

ORIG AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)